chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary congestion, SARS-CoV-2 test positive, Transient ischaemic attack
Clinical narrative: Patient is fully vaccinated.  COVID + on admission to hospital.  84-year-old female who presented to the hospital with altered mental status, found to be in the setting of acute hypoxic respiratory failure due to covid 19 pneumonia. CXR: Findings suggest mild pulmonary vascular congestion with a right basilar airspace opacity and a small to moderate right pleural effusion. She was treated with supplemental oxygen, IV steroids, breathing treatments.  She was also treated with IV remdesivir And completed the full 5 day course.  Her mentation improved back to baseline.  She also had a TIA and was provided with IV hydration, which improved her AKI. Cr 1.25. D-dimer is elevated. Discharged -home care services.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, C1 esterase inhibitor test, Complement factor C4, Full blood count
Clinical narrative: Facial angioedema two days after receiving the vaccine.  Recurred two days alter
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: PATIENT WAS GIVEN AN ADDITIONAL BOOSTER SHOT OF MODERNA'S COVID-19 VACCINE. HIS ORIGINAL BOOSTER WAS GIVEN ON 12/10/2021. HIS SECOND BOOSTER WAS ADMINISTERED ON 02/03/2022. THIS MORNING, THE NURSE ON THE UNIT REPORTED PATIENT SAID "I FEEL WEAK".
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Loss of personal independence in daily activities
Clinical narrative: Severe increased pain and quantity of blood loss during period. The already strong menstrual symptoms were heightened further impacting daily activities.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Headache, Heart rate increased, Myalgia, Pyrexia
Clinical narrative: Chest Pain, Muscle Aches, Headaches, Fever, Increased heart rate.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: PATIENT WAS GIVEN AN ADDITIONAL BOOSTER DOSE OF MODERNA'S COVID-19 VACCINE. HIS ORGINAL BOOSTER WAS GIVEN ON 12/10/2021. HIS SECOND BOOSTER WAS GIVEN ON 02/03/2022.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Chest X-ray normal, Chest discomfort, Cough
Clinical narrative: Patient is fully vaccinated. 63yo M with PMHx of neurosarcoidosis, HLD and vertigo presents with shortness of breath. Reports he tested positive for COVID 2 days ago and since that time has been having cough, worsening shortness of breath and chest discomfort. No history of heart attack, stroke or blood clots. Does not wear oxygen at home. Reports he had a fall a few days ago. No LOC, head trauma or blood thinner use. In the ER, he was placed on oxygen and given steroids and robitussin with significant improvement in his symptoms. CXR was negative for focal infiltrate. DVT prophylaxis with Lovenox. Discharged home.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fall, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated. 63yo M with PMHx of neurosarcoidosis, HLD and vertigo presents with shortness of breath. Reports he tested positive for COVID 2 days ago and since that time has been having cough, worsening shortness of breath and chest discomfort. No history of heart attack, stroke or blood clots. Does not wear oxygen at home. Reports he had a fall a few days ago. No LOC, head trauma or blood thinner use. In the ER, he was placed on oxygen and given steroids and robitussin with significant improvement in his symptoms. CXR was negative for focal infiltrate. DVT prophylaxis with Lovenox. Discharged home.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph or gland in arm pit that has lasted one full year after vaccination
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Feeling cold, Malaise
Clinical narrative: Started getting really cold and shivering around 11:30 pm woke up around 12:00 am shivering uncontrollably tried to sip on some water and then got really sick and threw up. Was really tired and weak and shaky all day the next day .
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder, Tremor, Vomiting
Clinical narrative: Started getting really cold and shivering around 11:30 pm woke up around 12:00 am shivering uncontrollably tried to sip on some water and then got really sick and threw up. Was really tired and weak and shaky all day the next day .
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Hypophagia, Impaired work ability, Oral herpes, Stomatitis
Clinical narrative: Almost 3 days after receiving the Moderna Booster, I have broken out with the worst case of cold sores on my lips and sores inside my mouth. To the point I cannot eat and barely drink. I have had herpes simplex 1 since I was a child but never have I experienced ANYTHING like this!  All I can do is wait it out and use the topical treatment creams but I cannot go outside or to work like this!
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram, Carotid artery dissection, Carotid artery occlusion, Carotid artery thrombosis, Cerebral artery occlusion
Clinical narrative: Spontaneous left carotid artery dissection, resulting in blockage of left internal carotid artery and the left middle cerebral artery by blood clots; therefore resulting in ischemic stroke. Received TPA and mechanical thrombectomy to remove clots.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral artery thrombosis, Ischaemic stroke, Magnetic resonance imaging, Scan with contrast, Thrombectomy
Clinical narrative: Spontaneous left carotid artery dissection, resulting in blockage of left internal carotid artery and the left middle cerebral artery by blood clots; therefore resulting in ischemic stroke. Received TPA and mechanical thrombectomy to remove clots.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Anticoagulant therapy, Blood culture negative, COVID-19, Cardiomegaly, Chest X-ray abnormal
Clinical narrative: Patient is a 75 y.o. female who presented with fever, chills, congestion, SOB, HA, and productive cough for 10 days. In the ED she was hypoxic and provided supplemental oxygen. She was found to be COVID-19+ and CXR showed suspected RLL pneumonia with mild fluid overload, but she was clinically euvolemic. She had a leukocytosis as well. She was started on antibiotics for community acquired pneumonia as well as given IV steroids for acute exacerbation of her underlying COPD and COVID+ status. She was admitted to the hospitalist service for further management and evaluation. At admission she was switched to Decadron and prophylactic dose Lovenox. She was outside of the treatment window for remdesivir. Given her new oxygen requirement and risk of deterioration, treatment was intensified to IV steroids at approx. 1/mg/kg/day and full dose anticoagulation. Antibiotics for CAP coverage were continued with rocephin and doxycycline. She was mildly hyperglycemic d/t steroids and corrective insulin coverage was required. She was also started on IV Lasix 40 mg daily. Albuterol was also scheduled which helped her breathing and SOB as well. Over the course of her hospitalization, she was able to wean back to room air from low flow nasal cannula. Her steroids were weaned and her home dose of PO Lasix was provided on the morning of discharge. She was ultimately discharged home in stable and improved condition with antibiotics to finish CAP treatment as well as a prednisone taper as described above.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Chills, Chronic obstructive pulmonary disease, Computerised tomogram abnormal, Condition aggravated, Dyspnoea
Clinical narrative: Patient is a 75 y.o. female who presented with fever, chills, congestion, SOB, HA, and productive cough for 10 days. In the ED she was hypoxic and provided supplemental oxygen. She was found to be COVID-19+ and CXR showed suspected RLL pneumonia with mild fluid overload, but she was clinically euvolemic. She had a leukocytosis as well. She was started on antibiotics for community acquired pneumonia as well as given IV steroids for acute exacerbation of her underlying COPD and COVID+ status. She was admitted to the hospitalist service for further management and evaluation. At admission she was switched to Decadron and prophylactic dose Lovenox. She was outside of the treatment window for remdesivir. Given her new oxygen requirement and risk of deterioration, treatment was intensified to IV steroids at approx. 1/mg/kg/day and full dose anticoagulation. Antibiotics for CAP coverage were continued with rocephin and doxycycline. She was mildly hyperglycemic d/t steroids and corrective insulin coverage was required. She was also started on IV Lasix 40 mg daily. Albuterol was also scheduled which helped her breathing and SOB as well. Over the course of her hospitalization, she was able to wean back to room air from low flow nasal cannula. Her steroids were weaned and her home dose of PO Lasix was provided on the morning of discharge. She was ultimately discharged home in stable and improved condition with antibiotics to finish CAP treatment as well as a prednisone taper as described above.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Effusion, Gram stain positive, Headache, Hyperglycaemia, Hypervolaemia
Clinical narrative: Patient is a 75 y.o. female who presented with fever, chills, congestion, SOB, HA, and productive cough for 10 days. In the ED she was hypoxic and provided supplemental oxygen. She was found to be COVID-19+ and CXR showed suspected RLL pneumonia with mild fluid overload, but she was clinically euvolemic. She had a leukocytosis as well. She was started on antibiotics for community acquired pneumonia as well as given IV steroids for acute exacerbation of her underlying COPD and COVID+ status. She was admitted to the hospitalist service for further management and evaluation. At admission she was switched to Decadron and prophylactic dose Lovenox. She was outside of the treatment window for remdesivir. Given her new oxygen requirement and risk of deterioration, treatment was intensified to IV steroids at approx. 1/mg/kg/day and full dose anticoagulation. Antibiotics for CAP coverage were continued with rocephin and doxycycline. She was mildly hyperglycemic d/t steroids and corrective insulin coverage was required. She was also started on IV Lasix 40 mg daily. Albuterol was also scheduled which helped her breathing and SOB as well. Over the course of her hospitalization, she was able to wean back to room air from low flow nasal cannula. Her steroids were weaned and her home dose of PO Lasix was provided on the morning of discharge. She was ultimately discharged home in stable and improved condition with antibiotics to finish CAP treatment as well as a prednisone taper as described above.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Hypoxia, Inguinal hernia, Legionella test, Leukocytosis, Lung consolidation
Clinical narrative: Patient is a 75 y.o. female who presented with fever, chills, congestion, SOB, HA, and productive cough for 10 days. In the ED she was hypoxic and provided supplemental oxygen. She was found to be COVID-19+ and CXR showed suspected RLL pneumonia with mild fluid overload, but she was clinically euvolemic. She had a leukocytosis as well. She was started on antibiotics for community acquired pneumonia as well as given IV steroids for acute exacerbation of her underlying COPD and COVID+ status. She was admitted to the hospitalist service for further management and evaluation. At admission she was switched to Decadron and prophylactic dose Lovenox. She was outside of the treatment window for remdesivir. Given her new oxygen requirement and risk of deterioration, treatment was intensified to IV steroids at approx. 1/mg/kg/day and full dose anticoagulation. Antibiotics for CAP coverage were continued with rocephin and doxycycline. She was mildly hyperglycemic d/t steroids and corrective insulin coverage was required. She was also started on IV Lasix 40 mg daily. Albuterol was also scheduled which helped her breathing and SOB as well. Over the course of her hospitalization, she was able to wean back to room air from low flow nasal cannula. Her steroids were weaned and her home dose of PO Lasix was provided on the morning of discharge. She was ultimately discharged home in stable and improved condition with antibiotics to finish CAP treatment as well as a prednisone taper as described above.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: Pneumonia, Productive cough, Pulmonary congestion, Pyrexia, Respiratory tract congestion
Clinical narrative: Patient is a 75 y.o. female who presented with fever, chills, congestion, SOB, HA, and productive cough for 10 days. In the ED she was hypoxic and provided supplemental oxygen. She was found to be COVID-19+ and CXR showed suspected RLL pneumonia with mild fluid overload, but she was clinically euvolemic. She had a leukocytosis as well. She was started on antibiotics for community acquired pneumonia as well as given IV steroids for acute exacerbation of her underlying COPD and COVID+ status. She was admitted to the hospitalist service for further management and evaluation. At admission she was switched to Decadron and prophylactic dose Lovenox. She was outside of the treatment window for remdesivir. Given her new oxygen requirement and risk of deterioration, treatment was intensified to IV steroids at approx. 1/mg/kg/day and full dose anticoagulation. Antibiotics for CAP coverage were continued with rocephin and doxycycline. She was mildly hyperglycemic d/t steroids and corrective insulin coverage was required. She was also started on IV Lasix 40 mg daily. Albuterol was also scheduled which helped her breathing and SOB as well. Over the course of her hospitalization, she was able to wean back to room air from low flow nasal cannula. Her steroids were weaned and her home dose of PO Lasix was provided on the morning of discharge. She was ultimately discharged home in stable and improved condition with antibiotics to finish CAP treatment as well as a prednisone taper as described above.
Age: 75.0
Sex: F
Vaccine: COVID19, FLUA4
Symptoms: SARS-CoV-2 test positive, Sputum culture, Streptococcus test negative
Clinical narrative: Patient is a 75 y.o. female who presented with fever, chills, congestion, SOB, HA, and productive cough for 10 days. In the ED she was hypoxic and provided supplemental oxygen. She was found to be COVID-19+ and CXR showed suspected RLL pneumonia with mild fluid overload, but she was clinically euvolemic. She had a leukocytosis as well. She was started on antibiotics for community acquired pneumonia as well as given IV steroids for acute exacerbation of her underlying COPD and COVID+ status. She was admitted to the hospitalist service for further management and evaluation. At admission she was switched to Decadron and prophylactic dose Lovenox. She was outside of the treatment window for remdesivir. Given her new oxygen requirement and risk of deterioration, treatment was intensified to IV steroids at approx. 1/mg/kg/day and full dose anticoagulation. Antibiotics for CAP coverage were continued with rocephin and doxycycline. She was mildly hyperglycemic d/t steroids and corrective insulin coverage was required. She was also started on IV Lasix 40 mg daily. Albuterol was also scheduled which helped her breathing and SOB as well. Over the course of her hospitalization, she was able to wean back to room air from low flow nasal cannula. Her steroids were weaned and her home dose of PO Lasix was provided on the morning of discharge. She was ultimately discharged home in stable and improved condition with antibiotics to finish CAP treatment as well as a prednisone taper as described above.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Fatigue, Feeling cold
Clinical narrative: Shakes, Cold Chills, Headache, Blurry Vision, Nausea, Tiredness, Muscle Aches, Painful lymphnodes in right neck and arm, Vomiting, Diarrhea, Dizziness within first 48 hours. Headache, Vomiting, Diarrhea within 72 hours. Symptoms ongoing on day 4.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymph node pain, Lymphadenopathy, Myalgia, Nausea
Clinical narrative: Shakes, Cold Chills, Headache, Blurry Vision, Nausea, Tiredness, Muscle Aches, Painful lymphnodes in right neck and arm, Vomiting, Diarrhea, Dizziness within first 48 hours. Headache, Vomiting, Diarrhea within 72 hours. Symptoms ongoing on day 4.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vision blurred, Vomiting
Clinical narrative: Shakes, Cold Chills, Headache, Blurry Vision, Nausea, Tiredness, Muscle Aches, Painful lymphnodes in right neck and arm, Vomiting, Diarrhea, Dizziness within first 48 hours. Headache, Vomiting, Diarrhea within 72 hours. Symptoms ongoing on day 4.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1  3/23/21  ER2613 dose 2  4/13/21  EW0150
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19, Chest X-ray normal, Chest pain, Computerised tomogram abdomen abnormal
Clinical narrative: Patient is fully vaccinated and boosted on 10/2/2021.  COVID + 1/18/2022. 25-year-old female with a past medical history of GERD, peptic ulcer disease presented to the hospital with nausea and vomiting getting worse. CT abdomen and pelvis showed no acute abdomen or pelvic abnormalities and had a nodule in the lingular left lower lobe consistent with infectious process.Not a candidate for any Decadron or remdesivir, was able to tolerate diet without any complications.  Electrolytes replaced.  Hydrated. Discharged on 1/19/2022.  Readmitted on 1/20/2022. Patient admits to continuous vomiting, abdominal pain, chest pain.  Patient also admits to sore throat, denies drooling or difficulty in swallowing. Positive for shortness of breath. CT abd/pelvis with no acute process.  CXR: no acute process. Discharged with GI consult.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrolyte imbalance, Nausea, Oropharyngeal pain, Pulmonary mass
Clinical narrative: Patient is fully vaccinated and boosted on 10/2/2021.  COVID + 1/18/2022. 25-year-old female with a past medical history of GERD, peptic ulcer disease presented to the hospital with nausea and vomiting getting worse. CT abdomen and pelvis showed no acute abdomen or pelvic abnormalities and had a nodule in the lingular left lower lobe consistent with infectious process.Not a candidate for any Decadron or remdesivir, was able to tolerate diet without any complications.  Electrolytes replaced.  Hydrated. Discharged on 1/19/2022.  Readmitted on 1/20/2022. Patient admits to continuous vomiting, abdominal pain, chest pain.  Patient also admits to sore throat, denies drooling or difficulty in swallowing. Positive for shortness of breath. CT abd/pelvis with no acute process.  CXR: no acute process. Discharged with GI consult.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Patient is fully vaccinated and boosted on 10/2/2021.  COVID + 1/18/2022. 25-year-old female with a past medical history of GERD, peptic ulcer disease presented to the hospital with nausea and vomiting getting worse. CT abdomen and pelvis showed no acute abdomen or pelvic abnormalities and had a nodule in the lingular left lower lobe consistent with infectious process.Not a candidate for any Decadron or remdesivir, was able to tolerate diet without any complications.  Electrolytes replaced.  Hydrated. Discharged on 1/19/2022.  Readmitted on 1/20/2022. Patient admits to continuous vomiting, abdominal pain, chest pain.  Patient also admits to sore throat, denies drooling or difficulty in swallowing. Positive for shortness of breath. CT abd/pelvis with no acute process.  CXR: no acute process. Discharged with GI consult.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Echocardiogram, Ejection fraction normal, Electrocardiogram ST segment elevation
Clinical narrative: Patient is a 24-year-old male with a history of hearing loss who presents with chest pain x7 days.  Patient reports achy chest tightness is nonradiating times 10 days.  It is worse early in the morning.  He reports that is improved now but does report some gas and burping.  Patient denies any fever chills or body aches.  Patient denies any family history of cardiovascular disease.  Patient does report receiving his COVID vaccination 12 days ago.  This was the 2nd of 2 of Moderna.  Patient works as a landscaper.  Pt was admitted for evaluation and discharge with diagnosis of Viral Pericarditis with instructions for follow up with Cardiology.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Eructation, Flatulence, Pain, Red blood cell sedimentation rate normal, Troponin normal
Clinical narrative: Patient is a 24-year-old male with a history of hearing loss who presents with chest pain x7 days.  Patient reports achy chest tightness is nonradiating times 10 days.  It is worse early in the morning.  He reports that is improved now but does report some gas and burping.  Patient denies any fever chills or body aches.  Patient denies any family history of cardiovascular disease.  Patient does report receiving his COVID vaccination 12 days ago.  This was the 2nd of 2 of Moderna.  Patient works as a landscaper.  Pt was admitted for evaluation and discharge with diagnosis of Viral Pericarditis with instructions for follow up with Cardiology.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Viral pericarditis
Clinical narrative: Patient is a 24-year-old male with a history of hearing loss who presents with chest pain x7 days.  Patient reports achy chest tightness is nonradiating times 10 days.  It is worse early in the morning.  He reports that is improved now but does report some gas and burping.  Patient denies any fever chills or body aches.  Patient denies any family history of cardiovascular disease.  Patient does report receiving his COVID vaccination 12 days ago.  This was the 2nd of 2 of Moderna.  Patient works as a landscaper.  Pt was admitted for evaluation and discharge with diagnosis of Viral Pericarditis with instructions for follow up with Cardiology.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Fatigue; headaches; nausea; muscle ache
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Agitation, COVID-19, Cardiac failure, Condition aggravated
Clinical narrative: Patient with J+J vaccine on 12/07/21 who admitted to hospital for COVID complications and subsequently died.  Provider discharge summary below:  "48 YO with PMH of OSA/OHS, chronic hypercapnic respiratory failure, HTN, HFrEF, CKD4, T2DM, bipolar disorder, BPH. Presented to the ED 1/14 for a 3 day history of progressive SOB, orthopnea, PND and lower extremity edema; found to be COVID positive. Admitted for acute on chronic hypercapnic respiratory failure and decompensated heart failure. Initially started on a few L of oxygen and escalated to BiPAP. Since admission he has been very agitated, ripping off his BiPAP and eventually started on precedex. At that time was evaluated by ICU team. Significant agitation with concomitant respiratory failure led to intubation on 1/16/2022. He was placed on propofol and fentanyl drips and admitted to critical care.   Please see chart for entire ICU care.     On 2/2 after discussion with palliative care team, the family decided to extubate him to BiPap with the intention of not to re-intubate the patient if he failed BiPap.  Please see chart for full discussions.   Despite pt being on BiPap his saturations started to decrease around 11 PM on 2/2.  He was then made comfort measures. Family was at bedside throughout the night. Time of death 12:20 AM with family at beside."
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Dyspnoea paroxysmal nocturnal, Endotracheal intubation, Intensive care
Clinical narrative: Patient with J+J vaccine on 12/07/21 who admitted to hospital for COVID complications and subsequently died.  Provider discharge summary below:  "48 YO with PMH of OSA/OHS, chronic hypercapnic respiratory failure, HTN, HFrEF, CKD4, T2DM, bipolar disorder, BPH. Presented to the ED 1/14 for a 3 day history of progressive SOB, orthopnea, PND and lower extremity edema; found to be COVID positive. Admitted for acute on chronic hypercapnic respiratory failure and decompensated heart failure. Initially started on a few L of oxygen and escalated to BiPAP. Since admission he has been very agitated, ripping off his BiPAP and eventually started on precedex. At that time was evaluated by ICU team. Significant agitation with concomitant respiratory failure led to intubation on 1/16/2022. He was placed on propofol and fentanyl drips and admitted to critical care.   Please see chart for entire ICU care.     On 2/2 after discussion with palliative care team, the family decided to extubate him to BiPap with the intention of not to re-intubate the patient if he failed BiPap.  Please see chart for full discussions.   Despite pt being on BiPap his saturations started to decrease around 11 PM on 2/2.  He was then made comfort measures. Family was at bedside throughout the night. Time of death 12:20 AM with family at beside."
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Oedema peripheral, Orthopnoea, Oxygen saturation decreased, Positive airway pressure therapy, Respiratory failure
Clinical narrative: Patient with J+J vaccine on 12/07/21 who admitted to hospital for COVID complications and subsequently died.  Provider discharge summary below:  "48 YO with PMH of OSA/OHS, chronic hypercapnic respiratory failure, HTN, HFrEF, CKD4, T2DM, bipolar disorder, BPH. Presented to the ED 1/14 for a 3 day history of progressive SOB, orthopnea, PND and lower extremity edema; found to be COVID positive. Admitted for acute on chronic hypercapnic respiratory failure and decompensated heart failure. Initially started on a few L of oxygen and escalated to BiPAP. Since admission he has been very agitated, ripping off his BiPAP and eventually started on precedex. At that time was evaluated by ICU team. Significant agitation with concomitant respiratory failure led to intubation on 1/16/2022. He was placed on propofol and fentanyl drips and admitted to critical care.   Please see chart for entire ICU care.     On 2/2 after discussion with palliative care team, the family decided to extubate him to BiPap with the intention of not to re-intubate the patient if he failed BiPap.  Please see chart for full discussions.   Despite pt being on BiPap his saturations started to decrease around 11 PM on 2/2.  He was then made comfort measures. Family was at bedside throughout the night. Time of death 12:20 AM with family at beside."
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient with J+J vaccine on 12/07/21 who admitted to hospital for COVID complications and subsequently died.  Provider discharge summary below:  "48 YO with PMH of OSA/OHS, chronic hypercapnic respiratory failure, HTN, HFrEF, CKD4, T2DM, bipolar disorder, BPH. Presented to the ED 1/14 for a 3 day history of progressive SOB, orthopnea, PND and lower extremity edema; found to be COVID positive. Admitted for acute on chronic hypercapnic respiratory failure and decompensated heart failure. Initially started on a few L of oxygen and escalated to BiPAP. Since admission he has been very agitated, ripping off his BiPAP and eventually started on precedex. At that time was evaluated by ICU team. Significant agitation with concomitant respiratory failure led to intubation on 1/16/2022. He was placed on propofol and fentanyl drips and admitted to critical care.   Please see chart for entire ICU care.     On 2/2 after discussion with palliative care team, the family decided to extubate him to BiPap with the intention of not to re-intubate the patient if he failed BiPap.  Please see chart for full discussions.   Despite pt being on BiPap his saturations started to decrease around 11 PM on 2/2.  He was then made comfort measures. Family was at bedside throughout the night. Time of death 12:20 AM with family at beside."
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Patient is fully vaccinated and boosted on 10/12/2021.  COVID + 1/18/2022 on admission to hospital. 94-year-old male that presented with shortness of breath and cough.  Patient was found to have acute hypoxic respiratory failure.Patient improved through stay.  He received dexamethasone.  Patient continued to have cough but he did start feeling better by discharge. Had a chest x-ray, which showed stable chest without suspicious acute pulmonary or pleural abnormalities. BP 123/57  | Pulse 61  | Temp 98.3 °F (36.8 °C) (Oral)  | Resp (!) 26  | Ht 175.3 cm (5' 9")  | Wt 81.6 kg (180 lb)  | SpO2 96%  | BMI 26.58 kg/m² D dimer is elevated.  Lovenox. Required correction of electrolytes.  Discharged home.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrolyte imbalance, Fibrin D dimer increased, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated and boosted on 10/12/2021.  COVID + 1/18/2022 on admission to hospital. 94-year-old male that presented with shortness of breath and cough.  Patient was found to have acute hypoxic respiratory failure.Patient improved through stay.  He received dexamethasone.  Patient continued to have cough but he did start feeling better by discharge. Had a chest x-ray, which showed stable chest without suspicious acute pulmonary or pleural abnormalities. BP 123/57  | Pulse 61  | Temp 98.3 °F (36.8 °C) (Oral)  | Resp (!) 26  | Ht 175.3 cm (5' 9")  | Wt 81.6 kg (180 lb)  | SpO2 96%  | BMI 26.58 kg/m² D dimer is elevated.  Lovenox. Required correction of electrolytes.  Discharged home.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, Cerebrovascular accident, Death, Dizziness
Clinical narrative: Reporting event roughly 6-8 weeks after Pfizer Covid booster shot. For reference, the first two vaccine doses were as follows: 1st dose: 04/09/2021  Lot EN6203   2nd dose: 04/30/2021  Lot EP6955 As reported on this form, booster was administered on 11/05/2021 Symptoms of what was believed to be Covid 19 began on 01/02/2022- sore throat, fever of 101-103, extreme tiredness and achiness.  Produced a negative Covid test on 01/06/2022.  Family heard from on 01/13/2022 when he reported feeling some better to his mother, but was experiencing some dizziness and had knocked over and broken some things in his apartment (lived alone.)  This was attributed to his illness and being light-headed after getting up too soon.  Found unresponsive on 01/15/2022 and transported to hospital where he ultimately died.  Before he passed, he was found to have suffered multiple strokes probably in the weeks/days prior, and suffered a massive stroke in the 12-24 hours before being found unresponsive.  His platelets were also reported to be extremely low and he had atrial fibrillation.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Illness, Oropharyngeal pain, Pain, Platelet count decreased
Clinical narrative: Reporting event roughly 6-8 weeks after Pfizer Covid booster shot. For reference, the first two vaccine doses were as follows: 1st dose: 04/09/2021  Lot EN6203   2nd dose: 04/30/2021  Lot EP6955 As reported on this form, booster was administered on 11/05/2021 Symptoms of what was believed to be Covid 19 began on 01/02/2022- sore throat, fever of 101-103, extreme tiredness and achiness.  Produced a negative Covid test on 01/06/2022.  Family heard from on 01/13/2022 when he reported feeling some better to his mother, but was experiencing some dizziness and had knocked over and broken some things in his apartment (lived alone.)  This was attributed to his illness and being light-headed after getting up too soon.  Found unresponsive on 01/15/2022 and transported to hospital where he ultimately died.  Before he passed, he was found to have suffered multiple strokes probably in the weeks/days prior, and suffered a massive stroke in the 12-24 hours before being found unresponsive.  His platelets were also reported to be extremely low and he had atrial fibrillation.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, Unresponsive to stimuli
Clinical narrative: Reporting event roughly 6-8 weeks after Pfizer Covid booster shot. For reference, the first two vaccine doses were as follows: 1st dose: 04/09/2021  Lot EN6203   2nd dose: 04/30/2021  Lot EP6955 As reported on this form, booster was administered on 11/05/2021 Symptoms of what was believed to be Covid 19 began on 01/02/2022- sore throat, fever of 101-103, extreme tiredness and achiness.  Produced a negative Covid test on 01/06/2022.  Family heard from on 01/13/2022 when he reported feeling some better to his mother, but was experiencing some dizziness and had knocked over and broken some things in his apartment (lived alone.)  This was attributed to his illness and being light-headed after getting up too soon.  Found unresponsive on 01/15/2022 and transported to hospital where he ultimately died.  Before he passed, he was found to have suffered multiple strokes probably in the weeks/days prior, and suffered a massive stroke in the 12-24 hours before being found unresponsive.  His platelets were also reported to be extremely low and he had atrial fibrillation.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea, Pyrexia
Clinical narrative: Pt with type 2 diabetes requiring insulin and obstructive sleep apnea presented with shortness of breath, cough, and fever.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, Cardiac failure congestive, Catheterisation cardiac normal, Chest pain
Clinical narrative: Unknown if this is correlated or not. Pt with hx scleroderma. On 6/23/21 EF was >55%, RVSP 39 mmHg. On 1/11/22 presented with CP and elevated HS troponin (>9,000). Echo 1/11/22 showed severe hypokinesis of posterolateral wall with EF 40-45%. RVSP 37 mmHg. Cath 1/12/22 showed normal coronary anatomy. Patient had her first Moderna injection 1/28/22 and felt ill the next day. Symptoms progressed and she presented to hospital 1/30/22  with CHF sx. HS troponin 5,400. BNP 2200. Echo 1/31/22 showed EF 25% (global dysfunction), mod-sev MR, and RVSP >60 mmHg. Started milrinone. Hypotension has prohibited aggressive afterload reduction and BB. Now on dobutamine. The timing of the rapid deterioration of LV systolic function in relation to C-19 immunization is concerning. Labs 2/3/22: CRP 13.0 (nml <10); ESR 45. Patient still hospitalized.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased ventricular afterload, Echocardiogram abnormal, Ejection fraction decreased, Hypokinesia, Hypotension
Clinical narrative: Unknown if this is correlated or not. Pt with hx scleroderma. On 6/23/21 EF was >55%, RVSP 39 mmHg. On 1/11/22 presented with CP and elevated HS troponin (>9,000). Echo 1/11/22 showed severe hypokinesis of posterolateral wall with EF 40-45%. RVSP 37 mmHg. Cath 1/12/22 showed normal coronary anatomy. Patient had her first Moderna injection 1/28/22 and felt ill the next day. Symptoms progressed and she presented to hospital 1/30/22  with CHF sx. HS troponin 5,400. BNP 2200. Echo 1/31/22 showed EF 25% (global dysfunction), mod-sev MR, and RVSP >60 mmHg. Started milrinone. Hypotension has prohibited aggressive afterload reduction and BB. Now on dobutamine. The timing of the rapid deterioration of LV systolic function in relation to C-19 immunization is concerning. Labs 2/3/22: CRP 13.0 (nml <10); ESR 45. Patient still hospitalized.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular dysfunction, Malaise, Mitral valve incompetence, Red blood cell sedimentation rate increased, Right ventricular systolic pressure
Clinical narrative: Unknown if this is correlated or not. Pt with hx scleroderma. On 6/23/21 EF was >55%, RVSP 39 mmHg. On 1/11/22 presented with CP and elevated HS troponin (>9,000). Echo 1/11/22 showed severe hypokinesis of posterolateral wall with EF 40-45%. RVSP 37 mmHg. Cath 1/12/22 showed normal coronary anatomy. Patient had her first Moderna injection 1/28/22 and felt ill the next day. Symptoms progressed and she presented to hospital 1/30/22  with CHF sx. HS troponin 5,400. BNP 2200. Echo 1/31/22 showed EF 25% (global dysfunction), mod-sev MR, and RVSP >60 mmHg. Started milrinone. Hypotension has prohibited aggressive afterload reduction and BB. Now on dobutamine. The timing of the rapid deterioration of LV systolic function in relation to C-19 immunization is concerning. Labs 2/3/22: CRP 13.0 (nml <10); ESR 45. Patient still hospitalized.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Unknown if this is correlated or not. Pt with hx scleroderma. On 6/23/21 EF was >55%, RVSP 39 mmHg. On 1/11/22 presented with CP and elevated HS troponin (>9,000). Echo 1/11/22 showed severe hypokinesis of posterolateral wall with EF 40-45%. RVSP 37 mmHg. Cath 1/12/22 showed normal coronary anatomy. Patient had her first Moderna injection 1/28/22 and felt ill the next day. Symptoms progressed and she presented to hospital 1/30/22  with CHF sx. HS troponin 5,400. BNP 2200. Echo 1/31/22 showed EF 25% (global dysfunction), mod-sev MR, and RVSP >60 mmHg. Started milrinone. Hypotension has prohibited aggressive afterload reduction and BB. Now on dobutamine. The timing of the rapid deterioration of LV systolic function in relation to C-19 immunization is concerning. Labs 2/3/22: CRP 13.0 (nml <10); ESR 45. Patient still hospitalized.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Burning sensation, Pain, Pruritus, Psoriasis
Clinical narrative: Onset of rash and severe plaque psoriasis.  Severe pain, burning, itching all over my body.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Onset of rash and severe plaque psoriasis.  Severe pain, burning, itching all over my body.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: Pt has chronic kidney disease and diabetes and arrives with worsening shortness of breath and cough.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Auscultation, COVID-19, Cardiac arrest, Death, Dyspnoea
Clinical narrative: Patient with Pfizer vaccines x2, last dose 05/18/21, who admitted to hospital with COVID complications.  Provider discharge summary below:  "The patient presented to ED on 1/27 unresponsive following O2 saturation drops to the 50-60s. Per family report, multiple family members had tested positive for COVID 19 and the patient had subsequently developed fevers, SOB, and decreased oral intake with O2 saturatinos in the mid 70s on home O2 monitor. She was found to be COVID positive in the ED and started on BIPAP. She subsequently failed BIPAP support and required intubation on 1/28. Pt's respiratory status continued to decline despite maximal vent support and therapy. On 2/3, her O2 saturations continued to drop into low 70s despite max vent support and son made decision to make her a DNR. She developed PEA arrest at 1433 on 2/3 with pt's son at bedside. There were no doppler pulses or heart sounds noted on auscultation.  Decision was made to discontinue ventilatory support at 1440 and pt went into asystole at 1444. Time of death 1444."
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Exposure to SARS-CoV-2, Heart sounds abnormal, Hypophagia, Mechanical ventilation
Clinical narrative: Patient with Pfizer vaccines x2, last dose 05/18/21, who admitted to hospital with COVID complications.  Provider discharge summary below:  "The patient presented to ED on 1/27 unresponsive following O2 saturation drops to the 50-60s. Per family report, multiple family members had tested positive for COVID 19 and the patient had subsequently developed fevers, SOB, and decreased oral intake with O2 saturatinos in the mid 70s on home O2 monitor. She was found to be COVID positive in the ED and started on BIPAP. She subsequently failed BIPAP support and required intubation on 1/28. Pt's respiratory status continued to decline despite maximal vent support and therapy. On 2/3, her O2 saturations continued to drop into low 70s despite max vent support and son made decision to make her a DNR. She developed PEA arrest at 1433 on 2/3 with pt's son at bedside. There were no doppler pulses or heart sounds noted on auscultation.  Decision was made to discontinue ventilatory support at 1440 and pt went into asystole at 1444. Time of death 1444."
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Positive airway pressure therapy, Procedural failure, Pulse absent, Pulseless electrical activity
Clinical narrative: Patient with Pfizer vaccines x2, last dose 05/18/21, who admitted to hospital with COVID complications.  Provider discharge summary below:  "The patient presented to ED on 1/27 unresponsive following O2 saturation drops to the 50-60s. Per family report, multiple family members had tested positive for COVID 19 and the patient had subsequently developed fevers, SOB, and decreased oral intake with O2 saturatinos in the mid 70s on home O2 monitor. She was found to be COVID positive in the ED and started on BIPAP. She subsequently failed BIPAP support and required intubation on 1/28. Pt's respiratory status continued to decline despite maximal vent support and therapy. On 2/3, her O2 saturations continued to drop into low 70s despite max vent support and son made decision to make her a DNR. She developed PEA arrest at 1433 on 2/3 with pt's son at bedside. There were no doppler pulses or heart sounds noted on auscultation.  Decision was made to discontinue ventilatory support at 1440 and pt went into asystole at 1444. Time of death 1444."
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Respiratory depression, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: Patient with Pfizer vaccines x2, last dose 05/18/21, who admitted to hospital with COVID complications.  Provider discharge summary below:  "The patient presented to ED on 1/27 unresponsive following O2 saturation drops to the 50-60s. Per family report, multiple family members had tested positive for COVID 19 and the patient had subsequently developed fevers, SOB, and decreased oral intake with O2 saturatinos in the mid 70s on home O2 monitor. She was found to be COVID positive in the ED and started on BIPAP. She subsequently failed BIPAP support and required intubation on 1/28. Pt's respiratory status continued to decline despite maximal vent support and therapy. On 2/3, her O2 saturations continued to drop into low 70s despite max vent support and son made decision to make her a DNR. She developed PEA arrest at 1433 on 2/3 with pt's son at bedside. There were no doppler pulses or heart sounds noted on auscultation.  Decision was made to discontinue ventilatory support at 1440 and pt went into asystole at 1444. Time of death 1444."
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19, Vaccine breakthrough infection
Clinical narrative: Suspect COVID breakthrough case
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Mastitis, Pain, Pyrexia
Clinical narrative: Mastitis in right breast. Resulting in a high fever, body aches, headache and chills. Has been consistent since night of vaccination.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest pain, Chills, Cough
Clinical narrative: A 73-year-old male, who has a past medical history of asthma, hypertension, TB (tuberculosis), and Type 2 diabetes mellitus, presented to ED due to worsening shortness of air. The patient reported he began to feel short of breath around 09:00 on 12/30/2021. This progressively got worse, prompting the patient's family to call EMS. Constitutional: Positive for chills and fatigue. Negative for activity change, appetite change, diaphoresis, fever and unexpected weight change. HENT: Negative for congestion, ear pain, hearing loss, rhinorrhea, sore throat, trouble swallowing and voice change. Eyes: Negative for discharge and visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for apnea, chest tightness and wheezing. Cardiovascular: Positive for chest pain. Negative for palpitations. He completed Remdesivir while inpatient. Regarding Dexamethasone, it was felt the benefits outweigh the cost as given high risk of a poor outcome from COVID-19 pneumonia. Given elevated procalcitonin and elevated WBC, he was treated for CAP with ceftriaxone and azithro during hospitalization. Discharge Disposition/Condition/Disposition: Home. Condition: Stable (s/sx potential problems absent or manageable).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Pneumonia, Procalcitonin increased, SARS-CoV-2 test positive
Clinical narrative: A 73-year-old male, who has a past medical history of asthma, hypertension, TB (tuberculosis), and Type 2 diabetes mellitus, presented to ED due to worsening shortness of air. The patient reported he began to feel short of breath around 09:00 on 12/30/2021. This progressively got worse, prompting the patient's family to call EMS. Constitutional: Positive for chills and fatigue. Negative for activity change, appetite change, diaphoresis, fever and unexpected weight change. HENT: Negative for congestion, ear pain, hearing loss, rhinorrhea, sore throat, trouble swallowing and voice change. Eyes: Negative for discharge and visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for apnea, chest tightness and wheezing. Cardiovascular: Positive for chest pain. Negative for palpitations. He completed Remdesivir while inpatient. Regarding Dexamethasone, it was felt the benefits outweigh the cost as given high risk of a poor outcome from COVID-19 pneumonia. Given elevated procalcitonin and elevated WBC, he was treated for CAP with ceftriaxone and azithro during hospitalization. Discharge Disposition/Condition/Disposition: Home. Condition: Stable (s/sx potential problems absent or manageable).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: A 73-year-old male, who has a past medical history of asthma, hypertension, TB (tuberculosis), and Type 2 diabetes mellitus, presented to ED due to worsening shortness of air. The patient reported he began to feel short of breath around 09:00 on 12/30/2021. This progressively got worse, prompting the patient's family to call EMS. Constitutional: Positive for chills and fatigue. Negative for activity change, appetite change, diaphoresis, fever and unexpected weight change. HENT: Negative for congestion, ear pain, hearing loss, rhinorrhea, sore throat, trouble swallowing and voice change. Eyes: Negative for discharge and visual disturbance. Respiratory: Positive for cough and shortness of breath. Negative for apnea, chest tightness and wheezing. Cardiovascular: Positive for chest pain. Negative for palpitations. He completed Remdesivir while inpatient. Regarding Dexamethasone, it was felt the benefits outweigh the cost as given high risk of a poor outcome from COVID-19 pneumonia. Given elevated procalcitonin and elevated WBC, he was treated for CAP with ceftriaxone and azithro during hospitalization. Discharge Disposition/Condition/Disposition: Home. Condition: Stable (s/sx potential problems absent or manageable).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Pt. states that after receiving the 3rd dose of Moderna 11/09/2021, started experiencing symptoms 1 hr later of hives developing around the abdomen and chest. Pharmacist communications that evening with recommendations of self-treatment of Benadryl. Primary communication 12/01/2021 with no recommendations. Communications with recommendations of reporting. Symptoms estimated lasting for 1 week. Symptoms have subsided.
Age: 77.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Colon cancer metastatic, Metastases to liver
Clinical narrative: Metastatic colon cancer spread to liver. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID-19 vaccine.